Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
EBIAT
Ratios

Bluejay Diagnostics (BJDX) Shares Outstanding (2021 - 2023)

Bluejay Diagnostics' Shares Outstanding history spans 3 years, with the latest figure at $774.0 for Q4 2023.

  • On a quarterly basis, Shares Outstanding fell 69.36% to $774.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $774.0, a 69.36% decrease, with the full-year FY2023 number at $774.0, down 69.36% from a year prior.
  • Shares Outstanding hit $774.0 in Q4 2023 for Bluejay Diagnostics, down from $154893.0 in the prior quarter.
  • Over the last five years, Shares Outstanding for BJDX hit a ceiling of $1.0 million in Q2 2022 and a floor of $774.0 in Q4 2023.
  • Historically, Shares Outstanding has averaged $493593.1 across 3 years, with a median of $154893.0 in 2023.
  • Biggest five-year swings in Shares Outstanding: crashed 99.75% in 2022 and later grew 1.56% in 2023.
  • Tracing BJDX's Shares Outstanding over 3 years: stood at $1.0 million in 2021, then crashed by 99.75% to $2526.0 in 2022, then crashed by 69.36% to $774.0 in 2023.
  • Business Quant data shows Shares Outstanding for BJDX at $774.0 in Q4 2023, $154893.0 in Q3 2023, and $1.0 million in Q2 2023.